---
layout: page
permalink: workshops/session_9
---

### Topics Covered
- ICC driven sample sizes
- Current sample sizes for cancer studies based on available fecal samples
- Cautionary tales (e.g., TCGA analysis)
- Interacting with non-epidemiologists
- Willingness to provide fecal samples
- Microbiome interventions (the good and the bad)
- Within person variation

### Session Overview

This final session summarizes key concepts and addresses special considerations for epidemiological studies of the microbiome and cancer. We will discuss sample size considerations, study design challenges, and lessons learned from previous studies.

<br><br>
*Instructor: Vogtmann (MEB)*
